Literature DB >> 2117227

Cloning and sequencing of bovine apolipoprotein A-I cDNA and molecular evolution of apolipoproteins A-I and B-100.

C O'hUigin1, L Chan, W H Li.   

Abstract

We have cloned and sequenced bovine apoA-I cDNA. Comparison with the apoA-I sequences of six other vertebrates shows the bovine gene to be most similar to that of the dog. Estimates of substitution rates show that apoA-I evolves approximately 25% faster than an average gene in mammalian lineages. All portions of the coding region evolve at roughly similar rates, suggesting that global conformation is conserved. However, a region of the rat protein has evolved rapidly both relative to other portions of the rat sequence and relative to homologous regions in other mammals. To extend our analysis to other apolipoproteins, we compared four vertebrate apoB-100 sequences. Conserved regions were found to include two putative LDL receptor binding domains, in addition to several regions of unidentified function. Comparison of the apoA-I sequences and the apoB-100 sequences indicates that the latter evolve approximately 40% faster than the former and at twice the average rate for mammalian proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117227     DOI: 10.1093/oxfordjournals.molbev.a040608

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  2 in total

1.  Validation of human ApoB and ApoAI immunoturbidity assays for non-human primate dyslipidemia and atherosclerosis research.

Authors:  Zhu Chen; Alison M Strack; Alice C Stefanni; Ying Chen; Weizhen Wu; Yi Pan; Olga Urosevic-Price; Li Wang; Theresa McLaughlin; Neil Geoghagen; Michael E Lassman; Thomas P Roddy; Kenny K Wong; Brian K Hubbard; Amy M Flattery
Journal:  J Cardiovasc Transl Res       Date:  2011-03-11       Impact factor: 4.132

2.  Cloning and sequencing of bovine apolipoprotein E complementary DNA and molecular evolution of apolipoproteins E, C-I, and C-II.

Authors:  Y W Yang; L Chan; W H Li
Journal:  J Mol Evol       Date:  1991-06       Impact factor: 2.395

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.